Sensex rebounds 359 points; financial, pharma stocks key drivers

The 30-share Sensex finished 358.83 points or 0.69 per cent higher at 52,300.47. Intra-day, the index swung between a high of 52,346.35 and a low of 51,957.92

BSE, sensex, market, shares, stocks, trading, brokers, investment, investors, growth, results, Q, earnings
On the forex market front, the Indian rupee lost 9 paise to end at 73.06 against the US dollar on Thursday
Press Trust of India Mumbai
2 min read Last Updated : Jun 11 2021 | 12:14 AM IST
The BSE benchmark Sensex surged nearly 359 points to cl­ose above the 52,300-level on Thursday, with financial, pha­rma and IT shares gaining the most amid positive global cues.

The 30-share Sensex finished 358.83 points or 0.69 per cent higher at 52,300.47. Intra-day, the index swung between a high of 52,346.35 and a low of 51,957.92.

Similarly, the broader NSE Nifty climbed 102.40 points or 0.65 per cent to end at 15,737.75. On the Sensex chart, Bajaj Finance, Bajaj FinServ, SBI, IndusInd Bank, Dr Reddy's, Tech Mahindra, ITC and Kotak Bank were the prominent gainers – rising up to 7.29 per cent.

On the other hand, Bajaj Auto, Maruti, HCL Tech, Ultratech Cement, PowerGrid, ONGC and Nestle suffered losses. Of the 30 shares in the Sensex pack, 23 ended with gains.

Elsewhere in Asia, stock markets closed with gains ahead of crucial US inflation data for May.

On the forex market front, the Indian rupee lost 9 paise to end at 73.06 against the US dollar on Thursday.

"Many states have eased lockdown restrictions since the peaking of the second COVID wave in early May. The central bank is maintaining its accommodative stance, while the government has launched another fiscal package via the distribution of free vaccines and food," said Jen-Ai Chua, Equity Research Analyst Asia, Julius Baer.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Markets Sensex Niftystock market tradingfinancial stocksPharma stocks

Next Story